22157.jpg
Global STAT3 Inhibitors Market & Clinical Trials Outlook Report 2023-2028: Insights by Country, Indication, Organization & Phase
02 juin 2023 05h03 HE | Research and Markets
Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Global STAT3 Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The dysregulation of...
22157.jpg
China Cancer Antibodies Market Trends & Clinical Trials Analysis Report 2023: 30+ Cancer Antibodies Commercially Approved and More than 800 in Clinical Trials
31 mai 2023 05h03 HE | Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "China Cancer Antibodies Market Trends & Clinical Trials Insight 2023" report has been added to ResearchAndMarkets.com's offering. The current...
Global Checkpoint Inhibitors Market
Global Checkpoint Inhibitors Market Report 2023: Rising Number of Cancer Cases Drives Growth
24 avr. 2023 13h18 HE | Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Cancer Advances logo.jpg
Cancer Advances, Inc. Announces Issuance of New U.S. Patent
28 févr. 2023 02h00 HE | Cancer Advances Inc
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, announced that the U.S....
22157.jpg
Global STAT3 Inhibitors Market & Clinical Trials Outlook 2028: FDA and EMA Special Drug Designations to Ignite R&D Progress
27 janv. 2023 04h58 HE | Research and Markets
Dublin, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The "Global STAT3 Inhibitors Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The dysregulation of...
22157.jpg
Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth
15 déc. 2022 05h18 HE | Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...
22157.jpg
Immune Checkpoint Inhibitors Global Market Report 2022: Featuring Bristol-Myers Squibb, Merck, Novartis, Pfizer & More
29 nov. 2022 08h08 HE | Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market, by Drug Class, By Cancer Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...
image 1
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA)
06 sept. 2022 07h45 HE | Aesther Healthcare Acquisition Corp.
• Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol,...
Global Checkpoint Inhibitors Market
Global Checkpoint Inhibitors Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F Featuring AstraZeneca, Bristol-Myers Squibb, Merck & Co, Roche, Pfizer, Incyte, Novartis, and NewLink Genetics
29 juil. 2022 06h23 HE | Research and Markets
Dublin, July 29, 2022 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2022: By Drug, By Application, By End-Users" report has been added to ResearchAndMarkets.com's offering. ...
Global Metastatic Cancer Drug Market
The Worldwide Metastatic Cancer Drug Industry is Expected to Reach $68.3 Billion by 2028
30 juin 2022 05h33 HE | Research and Markets
Dublin, June 30, 2022 (GLOBE NEWSWIRE) -- The "Global Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Cancer Type, Route of Administration, Drug Class,...